IP Library › Assignment 073610/0424
Patent Assignment
Reel/Frame 073610/0424

Assignment of Assignor's Interest

Recorded: 2025-11-18 Pages: 54
Assignor
LYNDRA THERAPEUTICS, INC.
Executed: 2025-09-16
Assignee
ISP ACQUISITION COMPANY, INC.
20 MAGUIRE ROAD, LEXINGTON, MASSACHUSETTS, 02421
Covered Properties (88)
Gastric Residence Systems for Sustained Release of Therapeutic Agents and Methods of Use Thereof
Application: 15/769,949 →
Publication: US 2018/0311154
Geometric Configurations for Gastric Residence Systems
Application: 15/782,021 →
Publication: US 2019/0262265
Geometric Configurations for Gastric Residence Systems
Application: 18/637,281 →
Publication: US 2024/0342081
Gastric Residence Systems for Sustained Delivery of Adamantane-Class Drugs
Application: 16/333,582 →
Publication: US 2019/0231697
Materials Architecture for Gastric Residence Systems
Application: 16/303,118 →
Publication: US 2019/0254966
Materials Architecture for Gastric Residence Systems
Application: 18/825,519 →
Publication: US 2024/0423909
Gastric Residence Systems with Release Rate-Modulating Films
Application: 16/618,759 →
Publication: US 2020/0146979
Gastric Residence Systems with Release Rate-Modulating Films
Application: 18/667,866 →
Publication: US 2024/0382418
Encapsulation of Gastric Residence Systems
Application: 16/648,207 →
Publication: US 2020/0281851
Encapsulation of Gastric Residence Systems
Application: 19/068,466 →
Publication: US 2025/0195420
Encapsulation of Gastric Residence Systems
Application: 18/470,327 →
Publication: US 2024/0139102
Systems for Enteric Delivery of Therapeutic Agents
Application: 17/268,405 →
Publication: US 2021/0196627
Stomach Simulating Device
Application: 17/297,956 →
Publication: US 2022/0093006
Capsules and Capsule Coatings for Gastric Residence Dosage Forms
Application: 17/593,436 →
Publication: US 2022/0160642
Capsules and Capsule Coatings for Gastric Residence Dosage Forms
Application: 19/262,609 →
Coatings for Gastric Residence Dosage Forms
Application: 17/593,437 →
Publication: US 2022/0192995
Gastric Residence Systems Having a Filament for Improved Gastric Residence
Application: 17/774,126 →
Publication: US 2022/0409528
Gastric Residence Systems Having Arms with Controlled Stiffness for Improved Gastric Residence
Application: 17/774,445 →
Publication: US 2022/0387312
Formulations for Release-Rate Modulating Films for Gastric Residence Systems
Application: 17/774,127 →
Publication: US 2022/0387310
Polymeric Linkers for a Gastric Residence System
Application: 17/774,128 →
Publication: US 2023/0190941
Gastric Residence Systems for Administration of Active Agents
Application: 17/774,132 →
Publication: US 2022/0387311
Gastric Residence Systems for Administration of Risperidone
Application: 18/272,786 →
Publication: US 2024/0390270
Gastric Residence Systems Comprising Buprenorphine and Naloxone
Application: 18/289,331 →
Publication: US 2024/0252483
Gastric Residence Systems Comprising Methadone
Application: 18/289,326 →
Publication: US 2024/0335400
Metal Cores for Gastric Residence Systems
Application: 19/100,303 →
Dosage Forms for Gastric Retention
Application: 18/729,705 →
Risperidone Dosage Regimens with Gastric Residence Systems
Application: 19/111,982 →
Manufacturing Methods for Gastric Residence Systems
Application: 18/731,125 →
Publication: US 2024/0398701
Flexible Line Configurations for Gastric Residence Systems
Application: 19/082,659 →
Publication: US 2025/0295901
Sustained Gastric Release of Cetirizine
Application: 62/245,789 →
Sustained Gastric Release of Cetirizine
Application: 62/264,795 →
Sustained Gastric Release of Rosuvastatin
Application: 62/245,797 →
Sustained Gastric Release of Rosuvastatin
Application: 62/264,799 →
Residence Systems for Sustained Gastric Release of Therapeutic Agents and Methods of Use Thereof
Application: 62/264,806 →
Geometric Configurations for Gastric Residence Systems
Application: 62/264,811 →
Gastric Residence Systems for Sustained Delivery of Adamantane-Class Drugs
Application: 62/402,947 →
Gastric Residence Systems for Sustained Delivery of Adamantane-Class Drugs
Application: 62/490,466 →
Gastric Residence Systems for Sustained Delivery of Adamantane-Class Drugs
Application: 62/517,718 →
Materials Architecture for Gastric Residence Systems
Application: 62/342,798 →
Gastric Residence Systems with Release Rate-Modulating Films
Application: 62/517,732 →
Gastric Residence Systems with Release Rate-Modulating Films
Application: 62/566,111 →
Gastric Residence Systems with Release Rate-Modulating Films
Application: 62/652,128 →
Encapsulation of Gastric Residence Systems
Application: 62/561,043 →
Systems for Enteric Delivery of Therapeutic Agents
Application: 62/764,917 →
Stomach Simulating Device
Application: 62/774,802 →
Capsules and Capsule Coatings for Gastric Residence Dosage Forms
Application: 62/821,352 →
Coatings for Gastric Residence Dosage Forms
Application: 62/821,361 →
Gastric Residence Systems Having a Filament for Improved Gastric Residence
Application: 62/933,211 →
Gastric Residence Systems Having a Filament for Improved Gastric Residence
Application: 62/992,075 →
Gastric Residence Systems Having Arms with Controlled Stiffness for Improved Gastric Residence
Application: 62/933,210 →
Formulations for Release-Rate Modulating Films for Gastric Residence Systems
Application: 62/933,313 →
Polymeric Linkers for a Gastric Residence System
Application: 62/933,226 →
Gastric Residence Systems for Administration of Active Agents
Application: 62/933,348 →
Gastric Residence Systems for Administration of Risperidone
Application: 63/139,299 →
Gastric Residence Systems for Administration of Risperidone
Application: 63/174,497 →
Gastric Residence Systems Comprising Buprenorphine and Naloxone
Application: 63/184,734 →
Gastric Residence Systems Comprising Methadone
Application: 63/184,760 →
Metal Cores for Gastric Residence Systems
Application: 63/370,366 →
Dosage Forms for Gastric Retention
Application: 63/301,041 →
Dosage Forms for Gastric Retention
Application: 63/368,605 →
Risperidone Dosage Regimens with Gastric Residence Systems
Application: 63/377,961 →
Manufacturing Methods for Gastric Residence Systems
Application: 63/506,039 →
Suture Configurations for Gastric Residence Systems
Application: 63/567,323 →
Suture Configurations for Gastric Residence Systems
Application: 63/572,128 →
Gastric Residence Systems for Administration of Active Agents
Application: 63/052,905 →
Gastric Residence Systems for Sustained Release of Therapeutic Agents and Methods of Use Thereof
Geometric Configurations for Gastric Residence Systems
Gastric Residence Systems for Sustained Delivery of Adamantane-Class Drugs
Materials Architecture for Gastric Residence Systems
Gastric Residence Systems with Release Rate-Modulating Films
Encapsulation of Gastric Residence Systems
Systems for Enteric Delivery of Therapeutic Agents
Stomach Simulating Device
Capsules and Capsule Coatings for Gastric Residence Dosage Forms
Coatings for Gastric Residence Dosage Forms
Gastric Residence Systems Having a Filament for Improved Gastric Residence
Gastric Residence Systems Having Arms with Controlled Stiffness for Improved Gastric Residence
Formulations for Release-Rate Modulating Films for Gastric Residence Systems
Polymeric Linkers for a Gastric Residence System
Gastric Residence Systems for Administration of Active Agents
Gastric Residence Systems for Administration of Risperidone
Gastric Residence Systems Comprising Buprenorphine and Naloxone
Gastric Residence Systems Comprising Methadone
Dosage Forms for Gastric Retention
Metal Cores for Gastric Residence Systems
Risperidone Dosage Regimens with Gastric Residence Systems
Manufacturing Methods for Gastric Residence Systems
Flexible Line Configurations for Gastric Residence Systems
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 12, 2018
From: KANASTY, ROSEMARY; BELLINGER, ANDREW; GARDNER, COLIN; GRANT, TYLER
To: LYNDRA, INC.
Reel/Frame 046857/0323 →
Assignment of Assignor's Interest Oct 12, 2018
From: BELLINGER, ANDREW; KANASTY, ROSEMARY; GRANT, TYLER; GARDNER, COLIN
To: LYNDRA, INC.
Reel/Frame 047153/0085 →
Assignment of Assignor's Interest Aug 27, 2019
From: BELLINGER, ANDREW; KANASTY, ROSEMARY; YANG, JUNG HOON; CARTER, BENNETT
To: LYNDRA, INC.
Reel/Frame 050186/0822 →
Assignment of Assignor's Interest Nov 5, 2019
From: BELLINGER, ANDREW; KANASTY, ROSEMARY; GRANT, TYLER; BHISE, NUPURA
To: LYNDRA, INC.
Reel/Frame 050921/0058 →
Change of Name May 7, 2021
From: LYNDRA, INC.
To: LYNDRA THERAPEUTICS, INC.
Reel/Frame 056181/0492 →
Assignment of Assignor's Interest May 18, 2021
From: GRANT, TYLER; WALDEMAR RYDE, ERIK ROBERT; KNOX, RAYMOND PATRICK; BISHOFF, MEGAN
To: LYNDRA, INC.
Reel/Frame 056278/0942 →
Assignment of Assignor's Interest Jan 24, 2022
From: KANASTY, ROSEMARY; GRANT, TYLER; PEEKE, ERICK; BHISE, NUPURA
To: LYNDRA THERAPEUTICS, INC.
Reel/Frame 058824/0078 →
Assignment of Assignor's Interest Jan 24, 2022
From: BHISE, NUPURA; PEEKE, ERICK; SCHWARZ, MARLENE; BISHOFF, MEGAN
To: LYNDRA THERAPEUTICS, INC.
Reel/Frame 058824/0012 →
Assignment of Assignor's Interest Mar 14, 2022
From: GRANT, TYLER; KANASTY, ROSEMARY; ALTREUTER, DAVID; BELLINGER, ANDREW
To: LYNDRA, INC.
Reel/Frame 059259/0873 →
Security Interest Jul 13, 2022
From: LYNDRA THERAPEUTICS, INC.
To: ISP HOLDINGS LLC
Reel/Frame 060499/0525 →
Assignment of Assignor's Interest Aug 11, 2022
From: KANASTY, ROSEMARY; BHISE, NUPURA; ZALE, STEPHEN; CARTER, BENNETT
To: LYNDRA THERAPEUTICS, INC.
Reel/Frame 061149/0216 →
Assignment of Assignor's Interest Aug 25, 2022
From: ALTREUTER, DAVID; WEIGHT, ALISHA; MOORTHY, SAUMYA; TAI, TAMMY
To: LYNDRA THERAPEUTICS, INC.
Reel/Frame 060904/0154 →
Assignment of Assignor's Interest Mar 16, 2023
From: MONTEZCO, JUAN JARAMILLO; SCHWARZ, MARLENE; KANASTY, ROSEMARY; ALTREUTER, DAVID
To: LYNDRA THERAPEUTICS, INC.
Reel/Frame 063002/0440 →
Assignment of Assignor's Interest Mar 24, 2023
From: KANASTY, ROSEMARY; GRANT, TYLER; MONTEZCO, JUAN JARAMILLO; ALTREUTER, DAVID
To: LYNDRA THERAPEUTICS, INC.
Reel/Frame 063093/0503 →
Assignment of Assignor's Interest Mar 24, 2023
From: KANASTY, ROSEMARY; GRANT, TYLER; HEALY, JOHN JAMES; PETERSON, BENJAMIN AUGUST ROTHENBERG
To: LYNDRA THERAPEUTICS, INC.
Reel/Frame 063163/0872 →
Change of Name Mar 24, 2023
From: LYNDRA, INC.
To: LYNDRA THERAPEUTICS, INC.
Reel/Frame 063164/0834 →
Assignment of Assignor's Interest Mar 24, 2023
From: DUFOUR, DAVID C.
To: LYNDRA, INC.
Reel/Frame 063092/0929 →
Assignment of Assignor's Interest Mar 24, 2023
From: KANASTY, ROSEMARY; GRANT, TYLER; ALTREUTER, DAVID; WEIGHT, ALISHA
To: LYNDRA THERAPEUTICS, INC.
Reel/Frame 063093/0598 →
Assignment of Assignor's Interest Mar 24, 2023
From: KANASTY, ROSEMARY; GRANT, TYLER; YANG, JUNG HOON; RYDE, ERIK ROBERT WALDEMAR
To: LYNDRA THERAPEUTICS, INC.
Reel/Frame 063093/0383 →
Corrective Assignment to Correct the 2ND Inventor's Middle Name Is "Robert Waldemar" and Their Last Name Is "Ryde" and Missing Page 2 of the Assignment Is Included Previously Recorded at Reel: 056278 Frame: 0942. Assignor(S) Hereby Confirms the Assignment. Aug 11, 2023
From: GRANT, TYLER; RYDE, ERIK ROBERT WALDEMAR; KNOX, RAYMOND PATRICK; BISHOFF, MEGAN
To: LYNDRA, INC.
Reel/Frame 064572/0125 →
Change of Name Sep 29, 2023
From: LYNDRA, INC.
To: LYNDRA THERAPEUTICS, INC.
Reel/Frame 065086/0571 →
Assignment of Assignor's Interest Sep 29, 2023
From: GRANT, TYLER; RYDE, ERIK ROBERT WALDEMAR; KNOX, RAYMOND PATRICK; BISHOFF, MEGAN
To: LYNDRA, INC.
Reel/Frame 065079/0118 →
Confirmatory License Dec 13, 2023
From: LYNDRA THERAPEUTICS, INC.
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 065987/0860 →
Release of Security Interest Dec 28, 2023
From: ISP HOLDINGS LLC
To: LYNDRA THERAPEUTICS, INC.
Reel/Frame 065970/0490 →
Assignment of Assignor's Interest Apr 22, 2024
From: BELLINGER, ANDREW; KANASTY, ROSEMARY; GRANT, TYLER; GARDNER, COLIN
To: LYNDRA, INC.
Reel/Frame 067181/0029 →